Chlamydia pneumoniae is recognised as a common cause of respiratory tract infections and has recently been implicated in several extrapulmonary chronic diseases, with great impact on public health, such as atherosclerosis, multiple sclerosis and Alzheimer's disease. The involvement of C. pneumoniae in such diseases may be correlated to characteristic features of this pathogen, including intracellular growth and ability to induce persistent forms. C. pneumoniae persistent forms are inherently more suited to evade the host immune response and are more difficult to eradicate by antibiotics. Our preliminary experimental findings show that interaction of C. pneumoniae with macrophages and/or T cells characterized by interference with TNF-<1. production, and redox state, culminates in the induction of T cell apoptosis and survival of infected macrophages. Based on our evidence, the poor cooperation between T cells and macrophages could lead to an inappropriate immune response against C.pneumoniae that may therefore promote the development of extrapulmonary chronic diseases.
Chlamydia pneumoniae (c. pneumoniae) is recognised as a common cause of respiratory tract infections such as pharyngitis, sinusitis, bronchitis and community-acquired pneumonia. Current opinion is that C. pneumoniae infection is implicated in several chronic extrapulmonary diseases such as atherosclerosis, multiple sclerosis, and Alzheimer's disease (1) (2) (3) (4) (5) . However, association of C. pneumoniae with multiple sclerosis and Alzheimer's disease remains highly controversial, whereas that with atherosclerosis has gained much support over the past years. Considering the public health importance of these pathologies, more interest in the role of C. pneumoniae in the development of . chronic diseases has re-emerged. The involvement of C. pneumoniae in the pathogenesis of chronic extrapulmonary diseases is supported by direct detection of chlamydial DNA in cerebrospinal fluid of multiple sclerosis patients, brains of affected Alzheimer subjects, and in atherosclerotic lesions (4) (5) (6) (7) . Of these chronic diseases, the strongest association has been with atherosclerosis in animal models, which provide causal evidence (8) and by direct detection of the microorganism in atherosclerotic lesions.
The involvement of C. pneumoniae in chronic extrapulmonary diseases may be correlated to the characteristic features of the microorganism. C. pneumoniae, an obligate intracellular pathogen has a unique developmental cycle with two functional and morphological forms: the elementary body (EB) and the reticulate body (RB). Recently, apart from EB and RB, a third non-replicating, non-infectious, and metabolically altered persistent form has been found in infected cells. These forms may persist for a long time inside the host-cell and remain viable in a culturenegative state. Persistent forms of C. pneumoniae have been characterized morphologically as aberrant bodies; they are inherently more suited to evade the host immune response and are more difficult to eradicate by antibiotics (8) . In vivo and in vitro infection models have demonstrated the evidence of persistent chlamydial infection. Several studies have shown that in mice infected intranasally with C. pneumoniae, chlamydia cannot be cultured from murine lung tissue, but is detectable by polymerase chain reaction (9) .
In vitro persistent chlamydial forms have been induced by depletion of host cell iron, glucose and essential amino acid levels, tobacco smoke-exposure (10), and treatment with cytokines, such as gamma interferon (IFN-y) or antibiotics (8) . Chlamydiae may be reactivated from persistence by removal of the growth inhibitory factor (8) . The persistent forms may favour C. pneumoniae survival and, hence, the development of chronic infections.
The other characteristic of C. pneumoniae is its ability to multiply in a wider array of host cell types including endothelial cells, smooth muscle cells and macrophages, resulting in production of proinflammatory cytokines and expression of cell surface molecules that may contribute to inflammation, a common factor of chronic diseases. Furthermore, C. pneumoniae is able to multiply into lymphocytes and peripheral blood mononuclear cells (PBMC). The presence of C. pneumoniae in PBMC supports the hypothesis of a systemic dissemination following exposure to respiratory infection, and in several studies C. pneumoniae DNA in PBMC has been proposed as a marker of chronic infection (11) (12) .
More interestingly, by using a highly sensitive and specific real-time PCR, we are able to quantify C. pneumoniae DNA in PBMC; the high chlamydial load more frequently found in patients with symptomatic atherosclerotic carotid disease suggests that measurement of bacterial load could be helpful to identify patients at risk of developing chronic diseases (13) . Therefore, the ability of C. pneumoniae to cause persistent infections combined with its ability to disseminate via the vascular system may explain the involvement of C. pneumoniae in chronic extrapulmonary diseases.
The main question that must be answered is how C. pneumoniae could mediate the development of chronic diseases. These should be a consequence of the features of C. pneumoniae, including intracellular growth and persistent forms, as well as its ability to modulate the apoptotic process in host cells and induce a cell-mediated immune response ( Fig. 1 ). We hypothesize that modulation of apoptosis in macrophages and/or T cells by C. pneumoniae infection may contribute to the pathogenesis of chronic disease. Preliminary results of our study show that interaction of C. pneumoniae with macrophages and/or T cells characterized by interference with TNF-a production, and redox state, culminates in the induction of T cell apoptosis and survival of infected macrophages (Sessa et al. manuscript in preparation).
The ability of C. pneumoniae to induce T cell apoptosis and to protect macrophages can be considered part of a coordinate strategy to inhibit the immune system, and simultaneously guarantee its own survival, as has been shown earlier in Chlamydia trachomatis infection (14) . Based on our evidence, the poor cooperation between T cells and macrophages could lead to an inappropriate immune response against C. pneumoniae that may promote the development of chronic diseases.
